SC
Sasirekha Chinnadurai
About Sasirekha Chinnadurai
Data last updated:
Sasirekha Chinnadurai is a Director at Innovative Therapeutics Private Limited (since 2008) and Director at Invocare Medtech Private Limited (since 2020). The companies operate in Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹47.93 Cr; the largest is Innovative Therapeutics Private Limited at ₹46.75 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Innovative Therapeutics Private Limited U33112TN2006PTC060347 | Director | 01 Oct 2008 | 2006 | ₹46.75 Cr (FY 2025) | Active |
 Invocare Medtech Private Limited U51909TN2020PTC135785 | Director | 13 Jun 2020 | 2020 | ₹1.19 Cr (FY 2025) | Active |
Board colleagues of Sasirekha Chinnadurai
| Name | DIN | Company | Designation |
|---|---|---|---|
| Saravanan Ramakrishnan Ellamanpettai | 00063303 | Innovative Therapeutics Private Limited , Invocare Medtech Private Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sasirekha Chinnadurai
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sasirekha Chinnadurai
Sasirekha Chinnadurai currently holds 2 directorships: Innovative Therapeutics Private Limited (Director, since 01 Oct 2008, revenue ₹46.75 Cr (FY 2025)); Invocare Medtech Private Limited (Director, since 13 Jun 2020, revenue ₹1.19 Cr (FY 2025)).
Sasirekha Chinnadurai was first appointed on 01 Oct 2008 as Director at Innovative Therapeutics Private Limited. The most recent appointment on record is 13 Jun 2020 at Invocare Medtech Private Limited.
The 2 current companies of Sasirekha Chinnadurai that report revenue have a combined latest revenue of ₹47.93 Cr: Innovative Therapeutics Private Limited ₹46.75 Cr (FY 2025); Invocare Medtech Private Limited ₹1.19 Cr (FY 2025).
The current boards of Sasirekha Chinnadurai's companies include Saravanan Ramakrishnan Ellamanpettai (Innovative Therapeutics Private Limited).